However, numerous studies of IV tPA therapy for acute myocardial infarction have found that with tPA in the therapeutic concentration range, plasminogen can also be converted to plasmin in contact with circulating fibrinogen owing to the incomplete fibrin specificity of tPA. This evidence concerns the gene PLAT and acute myocardial infarction.